BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16728325)

  • 1. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.
    Shibuya M
    Endothelium; 2006; 13(2):63-9. PubMed ID: 16728325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.
    Shibuya M; Claesson-Welsh L
    Exp Cell Res; 2006 Mar; 312(5):549-60. PubMed ID: 16336962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
    Shibuya M
    J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
    Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
    Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
    Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
    Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.
    Imai N; Shikami M; Miwa H; Suganuma K; Hiramatsu A; Watarai M; Satoh A; Itoh M; Imamura A; Mihara H; Nitta M
    Br J Haematol; 2006 Dec; 135(5):673-82. PubMed ID: 17107349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor.
    Imai N; Miwa H; Shikami M; Suganuma K; Gotoh M; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Shitara K; Shibuya M; Nitta M
    Leuk Res; 2009 Dec; 33(12):1650-7. PubMed ID: 19342098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF receptor trafficking in angiogenesis.
    Scott A; Mellor H
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1184-8. PubMed ID: 19909243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
    Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
    Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin.
    Yang Q; McHugh KP; Patntirapong S; Gu X; Wunderlich L; Hauschka PV
    Matrix Biol; 2008 Sep; 27(7):589-99. PubMed ID: 18640270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling.
    Mattila E; Auvinen K; Salmi M; Ivaska J
    J Cell Sci; 2008 Nov; 121(Pt 21):3570-80. PubMed ID: 18840653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoke-mediated oxidative stress, shear stress, and endothelial dysfunction: role of VEGFR2.
    Edirisinghe I; Rahman I
    Ann N Y Acad Sci; 2010 Aug; 1203():66-72. PubMed ID: 20716285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
    Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells.
    Sase H; Watabe T; Kawasaki K; Miyazono K; Miyazawa K
    J Cell Sci; 2009 Sep; 122(Pt 18):3303-11. PubMed ID: 19706681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
    Polverino A; Coxon A; Starnes C; Diaz Z; DeMelfi T; Wang L; Bready J; Estrada J; Cattley R; Kaufman S; Chen D; Gan Y; Kumar G; Meyer J; Neervannan S; Alva G; Talvenheimo J; Montestruque S; Tasker A; Patel V; Radinsky R; Kendall R
    Cancer Res; 2006 Sep; 66(17):8715-21. PubMed ID: 16951187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.